UBS O'Connor’s Kellanova K Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-3,533,015
Closed -$290M 278
2025
Q3
$290M Sell
3,533,015
-1,380,242
-28% -$110M 8.67% 3
2025
Q2
$391M Sell
4,913,257
-18,721
-0.4% -$1.53M 10.6% 1
2025
Q1
$407M Buy
4,931,978
+1,163,606
+31% +$95.5M 9.62% 4
2024
Q4
$305M Sell
3,768,372
-10,317
-0.3% -$833K 7.59% 3
2024
Q3
$305M Buy
+3,778,689
New +$269M 7.52% 2
2018
Q2
Sell
-99,279
Closed -$6.06M 320
2018
Q1
$6.06M Buy
+99,279
New +$6.27M 0.12% 90
2017
Q4
Sell
-149,765
Closed -$8.77M 337
2017
Q3
$8.77M Sell
149,765
-338,651
-69% -$21.4M 0.13% 133
2017
Q2
$31.9M Buy
488,416
+37,275
+8% +$2.51M 0.52% 43
2017
Q1
$30.8M Sell
451,141
-90,525
-17% -$6.25M 0.52% 39
2016
Q4
$37.5M Sell
541,666
-77,751
-13% -$5.41M 0.72% 28
2016
Q3
$45.1M Sell
619,417
-365,708
-37% -$28M 0.67% 30
2016
Q2
$75.5M Sell
985,125
-1,257,161
-56% -$90.2M 1.63% 7
2016
Q1
$161M Sell
2,242,286
-584,303
-21% -$40.3M 1.61% 8
2015
Q4
$192M Buy
2,826,589
+1,030,371
+57% +$67.3M 1.7% 7
2015
Q3
$112M Sell
1,796,218
-393,120
-18% -$24.5M 1.05% 19
2015
Q2
$129M Buy
+2,189,338
New +$131M 1.06% 15
2014
Q1
Sell
-474,264
Closed -$27.2M 483
2013
Q4
$27.2M Buy
+474,264
New +$27.3M 0.5% 59

Other funds holding K

UBS O'Connor's K Position: Q4 2025 in Review

UBS O'Connor sold out of Kellanova (K) in Q4 2025, closing a stake of 3,533,015 shares — an estimated $290M sold.

UBS O'Connor first reported a position in K in Q4 2013 and held it in 17 quarters. The position peaked at $407M in Q1 2025. 6 funds tracked by Wall St. Rank hold K as of Q4 2025.

  • UBS O'Connor reported no remaining Kellanova position as of Q4 2025 after selling out during the quarter.
  • UBS O'Connor sold 3,533,015 Kellanova shares in Q4 2025, an estimated $290M.
  • UBS O'Connor first reported a position in Kellanova in Q4 2013 and held it in 17 quarters.
  • UBS O'Connor's Kellanova position peaked at $407M in Q1 2025.
  • 6 funds tracked by Wall St. Rank held Kellanova as of Q4 2025.

Based on UBS O'Connor's 13F filing for Q4 2025, filed 13 Feb 2026.